Morgan Stanley upgrades Johnson & Johnson, says the stock is 'looking defensive again'

Johnson & Johnson products on a shelf in a store in New York.
Lucas Jackson | Reuters

Johnson & Johnson is in for a strong new year, according to Morgan Stanley.

The firm upgraded shares of Johnson & Johnson to overweight from neutral and hiked its 12-month price target to $170 from $145, as the company is "looking defensive again." The pharmaceutical and consumer packaged goods company closed at $141.79 per share on Monday. J&J also pays a 2.7% dividend yield.

"We see J&J's defensiveness returning, resulting in multiple expansion and outperformance in 2020," said Morgan Stanley equity analyst David Lewis in a note to clients on Tuesday.

More In Pro News and Analysis

CNBC ProChina's Gen Z are set to spend big – analysts pick 3 stocks that could be winners
CNBC ProUBS: These stocks are ‘best positioned’ to benefit as the chip shortage drags on
CNBC ProBlackRock's Rick Rieder says the Fed should send signal that it will step back from easy policies